An oxime O-ether that is benzene substituted by a (1E)-N-(2-aminoethoxy)-5-methoxypentanimidoyl group at position 1 and a trifluoromethyl group at position 4. It is a selective serotonin reuptake inhibitor that is used for the treatment of obsessive-compulsive disorder.
Synonyms: (1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentan-1-one O-(2-aminoethyl)oxime Fluvoxamine
Term information
- DrugBank:DB00176
- PMID:31807102
- PMID:18976545
- PMID:20025739
- PMID:30690950
- MetaCyc:CPD-20520
- PMID:31807753
- HMDB:HMDB0014322
- PMID:11825104
- Drug_Central:1230
- PMID:33180097
- KEGG:D07984
- KEGG:C07571
- PMID:10456487
- PMID:20573265
- PMID:9164424
- Chemspider:4481878
- PMID:32672818
- PMID:33392622
- PMID:29379174
- PMID:16316311
- PMID:12107854
- PMID:15686112
- PMID:7988100
- PDBeChem:FVX
- Patent:NL7503310
- Patent:US4085225
- PMID:24121440
- PMID:32618683
- Wikipedia:Fluvoxamine
- Beilstein:5583954
- CAS:54739-18-3
- PMID:30734885
- PMID:22859721
3_STAR
PMID:31807102
PMID:29379174
PDBeChem:FVX
PMID:18976545
Patent:US4085225
PMID:32618683
PMID:15686112
DrugBank:DB00176
PMID:33180097
PMID:16316311
PMID:9164424
PMID:32672818
PMID:22859721
PMID:10456487
KEGG:D07984
PMID:31807753
PMID:12107854
PMID:30690950
PMID:20025739
CAS:54739-18-3
PMID:24121440
Chemspider:4481878
MetaCyc:CPD-20520
HMDB:HMDB0014322
PMID:20573265
PMID:11825104
Wikipedia:Fluvoxamine
KEGG:C07571
Drug_Central:1230
Beilstein:5583954
PMID:7988100
PMID:33392622
Patent:NL7503310
PMID:30734885
fluvoxamine
2-{[(E)-{5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}amino]oxy}ethan-1-amine
O-(2-aminoethyl)-N-{(1E)-5-methoxy-1-[4-(trifluoromethyl)phenyl]pentylidene}hydroxylamine
fluvoxaminum
fluvoxamina
InChI=1S/C15H21F3N2O2/c1-21-10-3-2-4-14(20-22-11-9-19)12-5-7-13(8-6-12)15(16,17)18/h5-8H,2-4,9-11,19H2,1H3/b20-14+